My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 236

    1.

    Risk for valvular heart disease among users of fenfluramine and dexfenfluramine who underwent echocardiography before use of medication.

    Wee CC, Phillips RS, Aurigemma G, Erban S, Kriegel G, Riley M, Douglas PS.

    Ann Intern Med. 1998 Dec 1;129(11):870-4. Erratum in: Ann Intern Med 2000 Jan 18;132(2):167. PMID: 9867728 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine.

    Gardin JM, Schumacher D, Constantine G, Davis KD, Leung C, Reid CL.

    JAMA. 2000 Apr 5;283(13):1703-9.PMID: 10755496 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The progression of fenfluramine-associated valvular heart disease assessed by echocardiography.

    Mast ST, Jollis JG, Ryan T, Anstrom KJ, Crary JL.

    Ann Intern Med. 2001 Feb 20;134(4):261-6.PMID: 11182835 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine/fenfluramine.

    Gardin JM, Weissman NJ, Leung C, Panza JA, Fernicola D, Davis KD, Constantine GD, Reid CL.

    JAMA. 2001 Oct 24-31;286(16):2011-4.PMID: 11667938 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Echocardiographic prevalence of mitral and/or aortic regurgitation in patients exposed to either fenfluramine-phentermine combination or to dexfenfluramine.

    Kancherla MK, Salti HI, Mulderink TA, Parker M, Bonow RO, Mehlman DJ.

    Am J Cardiol. 1999 Dec 1;84(11):1335-8.PMID: 10614800 [PubMed - indexed for MEDLINE]Related articles

    6.

    Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine.

    Ryan DH, Bray GA, Helmcke F, Sander G, Volaufova J, Greenway F, Subramaniam P, Glancy DL.

    Obes Res. 1999 Jul;7(4):313-22.PMID: 10440587 [PubMed - indexed for MEDLINE]Related articles

    7.

    Echocardiographic improvement over time after cessation of use of fenfluramine and phentermine.

    Hensrud DD, Connolly HM, Grogan M, Miller FA, Bailey KR, Jensen MD.

    Mayo Clin Proc. 1999 Dec;74(12):1191-7.PMID: 10593346 [PubMed - indexed for MEDLINE]Related articles

    8.

    Low prevalence of valvular heart disease in 226 phentermine-fenfluramine protocol subjects prospectively followed for up to 30 months.

    Burger AJ, Sherman HB, Charlamb MJ, Kim J, Asinas LA, Flickner SR, Blackburn GL.

    J Am Coll Cardiol. 1999 Oct;34(4):1153-8.PMID: 10520805 [PubMed - indexed for MEDLINE]Related articles

    9.

    Operation for anorexigen-associated valvular heart disease.

    Caccitolo JA, Connolly HM, Rubenson DS, Orszulak TA, Schaff HV.

    J Thorac Cardiovasc Surg. 2001 Oct;122(4):656-64.PMID: 11581595 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effect of fenfluramine-derivative diet pills on cardiac valves: a meta-analysis of observational studies.

    Sachdev M, Miller WC, Ryan T, Jollis JG.

    Am Heart J. 2002 Dec;144(6):1065-73. Review.PMID: 12486432 [PubMed - indexed for MEDLINE]Related articles

    11.

    An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group.

    Weissman NJ, Tighe JF Jr, Gottdiener JS, Gwynne JT.

    N Engl J Med. 1998 Sep 10;339(11):725-32.PMID: 9731088 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Low risk of significant echocardiographic valvulopathy in patients treated with anorectic drugs.

    Burger AJ, Charlamb MJ, Singh S, Notarianni M, Blackburn GL, Sherman HB.

    Int J Cardiol. 2001 Jul;79(2-3):159-65.PMID: 11461737 [PubMed - indexed for MEDLINE]Related articles

    13.

    Diet drug-related cardiac valve disease: the Mayo Clinic echocardiographic laboratory experience.

    Teramae CY, Connolly HM, Grogan M, Miller FA Jr.

    Mayo Clin Proc. 2000 May;75(5):456-61.PMID: 10807073 [PubMed - indexed for MEDLINE]Related articles

    14.

    A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation.

    Jick H, Vasilakis C, Weinrauch LA, Meier CR, Jick SS, Derby LE.

    N Engl J Med. 1998 Sep 10;339(11):719-24.PMID: 9731087 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Appetite suppressants and valvular heart disease in a population-based sample: the HyperGEN study.

    Palmieri V, Arnett DK, Roman MJ, Liu JE, Bella JN, Oberman A, Kitzman DW, Hopkins PN, Morgan D, de Simone G, Devereux RB.

    Am J Med. 2002 Jun 15;112(9):710-5.PMID: 12079711 [PubMed - indexed for MEDLINE]Related articles

    16.

    Appetite-suppressing drugs and valvular heart disease.

    Cannistra LB, Gaasch WH.

    Cardiol Rev. 1999 Nov-Dec;7(6):356-61. Review.PMID: 11208248 [PubMed - indexed for MEDLINE]Related articles

    17.

    The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs.

    Khan MA, Herzog CA, St Peter JV, Hartley GG, Madlon-Kay R, Dick CD, Asinger RW, Vessey JT.

    N Engl J Med. 1998 Sep 10;339(11):713-8.PMID: 9731086 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Appetite suppressants and valvular heart disease - a systematic review.

    Loke YK, Derry S, Pritchard-Copley A.

    BMC Clin Pharmacol. 2002 Aug 23;2:6. Review.PMID: 12194699 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Natural history of valvular regurgitation 1 year after discontinuation of dexfenfluramine therapy. A randomized, double-blind, placebo-controlled trial.

    Weissman NJ, Panza JA, Tighe JF, Gwynne JT.

    Ann Intern Med. 2001 Feb 20;134(4):267-73.PMID: 11182836 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The longitudinal effects of fenfluramine-phentermine use.

    Fleming RM, Boyd LB.

    Angiology. 2007 Jun-Jul;58(3):353-9.PMID: 17626991 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity